Thenewswireยท2025-07-17 00:00Company Overview - Universal Ibogaine Inc. (UI) is a life sciences company focused on researching and delivering medicalized ibogaine-centered addiction care [1][3] - The company aims to transform addiction treatment through a planned Canadian clinical trial targeting opioid use disorder and intends to expand its treatment protocol globally via future licensing agreements [3] Leadership Changes - Greg Leavens has resigned from his position as Chief Financial Officer and Corporate Secretary to pursue other opportunities, but will assist the company in a consulting capacity during the transition [1][2] Treatment Protocols - UI is developing a state-of-the-art holistic addiction treatment protocol at its Kelburn Recovery Centre, located near Winnipeg, Manitoba, which will be paired with the planned ibogaine detox protocol [3]